These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14663182)

  • 21. Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease.
    Whiley L; Chappell KE; D'Hondt E; Lewis MR; Jiménez B; Snowden SG; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Swann JR; Hye A; Lovestone S; Legido-Quigley C; Holmes E;
    Alzheimers Res Ther; 2021 Jan; 13(1):20. PubMed ID: 33422142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid.
    Tóth F; Cseh EK; Vécsei L
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential Mechanism of Cellular Uptake of the Excitotoxin Quinolinic Acid in Primary Human Neurons.
    Braidy N; Alicajic H; Pow D; Smith J; Jugder BE; Brew BJ; Nicolazzo JA; Guillemin GJ
    Mol Neurobiol; 2021 Jan; 58(1):34-54. PubMed ID: 32894500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kynurenic Acid Levels are Increased in the CSF of Alzheimer's Disease Patients.
    González-Sánchez M; Jiménez J; Narváez A; Antequera D; Llamas-Velasco S; Martín AH; Arjona JAM; Munain AL; Bisa AL; Marco MP; Rodríguez-Núñez M; Pérez-Martínez DA; Villarejo-Galende A; Bartolome F; Domínguez E; Carro E
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32276479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IDO and Kynurenine Metabolites in Peripheral and CNS Disorders.
    Huang YS; Ogbechi J; Clanchy FI; Williams RO; Stone TW
    Front Immunol; 2020; 11():388. PubMed ID: 32194572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice.
    Fertan E; Stover KRJ; Brant MG; Stafford PM; Kelly B; Diez-Cecilia E; Wong AA; Weaver DF; Brown RE
    Front Pharmacol; 2019; 10():1044. PubMed ID: 31607909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development.
    Biber K; Bhattacharya A; Campbell BM; Piro JR; Rohe M; Staal RGW; Talanian RV; Möller T
    Front Pharmacol; 2019; 10():840. PubMed ID: 31507408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraventricular infusion of quinolinic acid impairs spatial learning and memory in young rats: a novel mechanism of lead-induced neurotoxicity.
    Rahman A; Rao MS; Khan KM
    J Neuroinflammation; 2018 Sep; 15(1):263. PubMed ID: 30217162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.
    Chatterjee P; Goozee K; Lim CK; James I; Shen K; Jacobs KR; Sohrabi HR; Shah T; Asih PR; Dave P; ManYan C; Taddei K; Lovejoy DB; Chung R; Guillemin GJ; Martins RN
    Sci Rep; 2018 May; 8(1):8008. PubMed ID: 29789640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seeding of proteins into amyloid structures by metabolite assemblies may clarify certain unexplained epidemiological associations.
    Sade D; Shaham-Niv S; Arnon ZA; Tavassoly O; Gazit E
    Open Biol; 2018 Jan; 8(1):. PubMed ID: 29367352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral Tryptophan - Kynurenine Metabolism Associated with Metabolic Syndrome is Different in Parkinson's and Alzheimer's Diseases.
    Oxenkrug G; van der Hart M; Roeser J; Summergrad P
    Endocrinol Diabetes Metab J; 2017 Nov; 1(4):. PubMed ID: 29292800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Toxicity of the Neurometabolites Quinolinic Acid and Homocysteine in Cortical Neurons and Astrocytes: Implications in Alzheimer's Disease.
    Pierozan P; Biasibetti-Brendler H; Schmitz F; Ferreira F; Netto CA; Wyse ATS
    Neurotox Res; 2018 Jul; 34(1):147-163. PubMed ID: 29124681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Chouraki V; Preis SR; Yang Q; Beiser A; Li S; Larson MG; Weinstein G; Wang TJ; Gerszten RE; Vasan RS; Seshadri S
    Alzheimers Dement; 2017 Dec; 13(12):1327-1336. PubMed ID: 28602601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major Developments in the Design of Inhibitors along the Kynurenine Pathway.
    Jacobs KR; Castellano-Gonzalez G; Guillemin GJ; Lovejoy DB
    Curr Med Chem; 2017; 24(23):2471-2495. PubMed ID: 28464785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased quinolinic acid in peripheral mononuclear cells in Alzheimer's dementia.
    Busse M; Hettler V; Fischer V; Mawrin C; Hartig R; Dobrowolny H; Bogerts B; Frodl T; Busse S
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):493-500. PubMed ID: 28386767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TDO as a therapeutic target in brain diseases.
    Yu CP; Pan ZZ; Luo DY
    Metab Brain Dis; 2016 Aug; 31(4):737-47. PubMed ID: 27072164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?
    Lewerenz J; Maher P
    Front Neurosci; 2015; 9():469. PubMed ID: 26733784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases.
    Fan HC; Chi CS; Cheng SN; Lee HF; Tsai JD; Lin SZ; Harn HJ
    Int J Mol Sci; 2015 Dec; 17(1):. PubMed ID: 26712747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memantine and Kynurenic Acid: Current Neuropharmacological Aspects.
    Majláth Z; Török N; Toldi J; Vécsei L
    Curr Neuropharmacol; 2016; 14(2):200-9. PubMed ID: 26564141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
    Mazarei G; Leavitt BR
    J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.